Veterinary Medicines

Gallimune Se + St, water-in oil emulsion for injection

Authorised
  • Salmonella enterica, subsp. enterica, serovar Enteritidis, strain PT4, Inactivated
  • Salmonella enterica, subsp. enterica, serovar Typhimurium, strain DT104, Inactivated
Download as PDF

Product identification

Medicine name:
Gallimune Se + St, water-in oil emulsion for injection
GALLIMUNE SE + ST
Active substance:
  • Salmonella enterica, subsp. enterica, serovar Enteritidis, strain PT4, Inactivated
  • Salmonella enterica, subsp. enterica, serovar Typhimurium, strain DT104, Inactivated
Target species:
  • Chicken (pullet)
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Salmonella enterica, subsp. enterica, serovar Enteritidis, strain PT4, Inactivated
    171.00
    antibody unit(s)
    /
    0.30
    millilitre(s)
  • Salmonella enterica, subsp. enterica, serovar Typhimurium, strain DT104, Inactivated
    149.00
    antibody unit(s)
    /
    0.30
    millilitre(s)
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Chicken (pullet)
      • Meat and offal
        0
        day
      • Egg
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AB01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:
  • (ID2) 3000 millilitre(s): Box (Cardboard) with 10 Bottle (PolyPropylene) each with 300 millilitre(s)
  • (ID1) 300 millilitre(s): Box (Cardboard) with 1 Bottle (PolyPropylene) with 300 millilitre(s)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health Italia S.p.A.
Responsible authority:
  • National Veterinary Medicines Agency
Authorisation number:
  • FR/V/8252314 5/2007
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0282/001
Concerned member states:
  • Austria
  • Belgium
  • Cyprus
  • Czechia
  • Denmark
  • France
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Poland
  • Portugal
  • Slovakia
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 10/02/2022
Download
French (PDF)
Published on: 4/04/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."